´ëÇѼҾƽÉÀåÇÐȸ (¿Â¶óÀÎ) ¼Ò¾ÆÆóµ¿¸Æ °íÇ÷¾Ð ½ÉÆ÷Áö¾ö : 2021-03-26±³À°ÀÏÀÚ : 2021-03-26
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) ¼Ò¾ÆÆóµ¿¸Æ °íÇ÷¾Ð ½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇѼҾƽÉÀåÇÐȸ
´ã´çÀÚ : ¼ÛÁø¿µ
¿¬¶ôó : 02-3410-0647
À̸ÞÀÏ :
pediheart@pediheart.or.kr ±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í Àü¹®ÀÇ (50,000) Àü°øÀÇ, °£È£»ç, ±â»ç, ±âŸ (40,000) Çлý(¹«·á)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 14:00~14:20 Nitric oxide revisit including iNOmax Çϱâ¼ö(°í´ë±¸·Î º´¿ø)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 14:20~14:40 Riociguat in the pediatric population and clinical application Á¤Á¶¿ø(¼¼ºê¶õ½º º´¿ø)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 14:40~15:00 IV Epoprestenol, preparation to use ¾È°æÁø(±æ º´¿ø)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 15:00~15:20 Pulmonary vasodilator in Fontan patient, update ±è±â¹ü(¼¿ï´ë º´¿ø)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 15:20~15:40 Korean pulmonary hypertension guideline review Â÷½½±â(¼¿ï¾Æ»êº´¿ø)
Åä·Ð 03¿ù 26ÀÏ ¿Â¶óÀÎ 15:40~16:00 Åä·Ð ()
ÈÞ½Ä 03¿ù 26ÀÏ 16:00~16:20 ÈÞ½Ä ()
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 16:20~16:30 Overcome of pulmonary hypertension applying BiPAP for infant with lung hypoplasia ±è¿©Çâ(°æºÏ´ë º´¿ø)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 16:30~16:40 ±¸¿¬2 °¡°»ç(¼¿ï¼º¸ð º´¿ø)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 16:40~16:50 ±¸¿¬3 ³ª°»ç(¼¿ï¾Æ»ê º´¿ø)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 16:50~17:00 ±¸¿¬4 ´Ù°»ç(¼¼ºê¶õ½º º´¿ø)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 17:00~17:10 Successful treatment of subcutaneous treprostinil for pulmonary hypertension with bronchopulmonary dysplasia in an extremely premature infant °íÈÆ(¾ç»ê ºÎ»ê´ë º´¿ø)
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀÎ 17:10~17:20 ±¸¿¬6 ¶ó°»ç(¼¼Á¾ º´¿ø)